Related Experiment Videos

Negative CDX2 expression can be an important predictive and prognostic biomarker in stage II colon cancer

Burak Bilgin¹, Mehmet A Sendur, Muhammed B Akinci

¹Yildirim Beyazit University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology

|April 3, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Cancers·2026

Prognostic ımpact of the modified Ryan tumor regression score in gastric and GEJ adenocarcinomas treated with neoadjuvant FLOT regimen.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis.

The oncologist·2026

Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.

Journal of clinical medicine·2026

Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study.

Cancers·2026

Programmable low-coherence wavefronts for enhanced localization.

Communications engineering·2025

See all related articles